Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies

Clinical trial NCT05213572 · RECRUITING

Trial details

NCT number: NCT05213572
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: RECRUITING
Study type: OBSERVATIONAL

Mortality in Sickle Cell Sickle Cell Cardiopulmonary Complications Sickle Cell Organ Damage Sickle Cell Life Expectancy and Risk Factors for Early Death Sickle Cell Lung Disease and Sudden Death

Start date: 2022-03-24
Primary completion: 2035-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.